In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release.
Wang Y, Goodman M, Lumerman J, Sussman KE, Dahl R, Lafferty KJ, Draznin B. In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release. Diabetes Res Clin Pract. 1989 Sep 18; 7(3):205-11.